These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Interaction of supraspinally administered interferon-α with opioid system in the production of antinociception.
    Author: Lee JK, Park SH, Sim YB, Jung JS, Suh HW.
    Journal: Arch Pharm Res; 2010 Jul; 33(7):1059-63. PubMed ID: 20661716.
    Abstract:
    We examined the antinociceptive effect of intracerebroventricularly (i.c.v.) or intrathecally (i.t.) administered of interferon-alpha (IFN-alpha) using the tail-flick analgesic test in mice. IFN-alpha administered i.c.v. but not i.t. showed an antinociceptive effect in a dose-dependent manner (0.05-5 microg). To examine the possible interaction with brain opioid system, IFN-alpha was cotreated with either beta-endorphin or morphine. Combined i.c.v. treatment of IFN-alpha (0.5 microg) with beta-endorphin (0.125 microg) caused a synergistic antinociceptive effect. And also, the synergistic interaction maintained at least for 60 min after the co-treatment of IFN-alpha and beta-endorphin. However, the combined treatment of i.t. IFN-alpha with i.c.v. beta-endorphin showed neither an additive nor a synergistic antinociceptive profile. The i.c.v. co-treatment of IFN-alpha with morphine (0.2 microg) showed an additive antinociceptive effect only. The i.t. administered IFN-alpha did not show any additive antinociceptive effect when morphine was administered i.c.v. simultaneously. Taken together, our results suggest that supraspinally co-administered IFN-alpha and beta-endorphin may produce antinociception synergistically via interaction of IFN-alpha with supraspinal beta-endorphin sensitive opioid receptors.
    [Abstract] [Full Text] [Related] [New Search]